• Salvianolic Acid B and LH2 in Pulmonary Fibrosis

  2026-08-24

  The reference study identifies lysyl hydroxylase 2 (LH2/PLOD2) as a collagen cross-linking target through which Salvianolic acid B limits pulmonary fibrosis. By combining LH2 silencing, TGF-β1-stimulated cellular models, and pulmonary fibrosis tissue-level analyses, the work connects extracellular matrix remodeling with EMT, fibroblast-to-myofibroblast transition, and Wnt/β-catenin signaling. These findings support mechanism-guided use of Dan Shen Suan B in pulmonary fibrosis research while leaving questions about direct enzyme inhibition, dosing, and clinical translation unresolved.

• Podophyllotoxin: Mechanism, HCC Research & Workflows

  2026-08-24

  Podophyllotoxin is a microtubule-targeting cell cycle arrest agent used in anticancer drug research. This guide separates validated Podophyllotoxin biology from related JXE-23 findings in hepatocellular carcinoma and provides source-linked workflow guidance.

• Tacrine-Based Hybrids in Alzheimer’s Research

  2026-08-23

  The 2023 review examines how tacrine has been redesigned as a multi-target scaffold for Alzheimer’s disease drug discovery despite its clinical hepatotoxicity. Its main practical contribution is a comparative view of tacrine hybrids that combine cholinesterase inhibition with activities directed at amyloid aggregation, oxidative stress, metal imbalance, tau pathology, and other disease mechanisms.

• Cleavage-Resistant TREM2 Restores Macrophage Efferocytosis

  2026-08-22

  Dong et al. engineered a cleavage-resistant TREM2 receptor that preserves macrophage efferocytosis despite inflammatory ADAM17 activity. Phosphatidylserine-functionalized lipid nanoparticles delivered the receptor’s mRNA in situ, reducing apoptotic-cell accumulation and inflammation in mouse models of MASH and atherosclerosis.

• Hypoxia and Immunometabolism in the Tumor Microenvironment

  2026-08-21

  This 2025 review integrates tumor hypoxia, metabolic competition, and immune-cell dysfunction into a dynamic model of immunosuppressive tumor-microenvironment development. Its main practical implication is that therapeutic studies should measure oxygen-sensitive signaling, nutrient use, immune phenotype, and tumor behavior together rather than treating these processes as independent variables.

• MK0787 vs Cefoperazone: Comparative β-Lactam Activity

  2026-08-20

  Cullmann and colleagues compared N-formimidoyl thienamycin (MK0787) with cefoperazone and other newer β-lactams across 470 clinical isolates, emphasizing activity against resistant gram-negative and selected gram-positive organisms. MK0787 showed especially strong bactericidal activity against gram-negative isolates and the best performance against Pseudomonas aeruginosa and Acinetobacter spp., while its relative activity varied by bacterial genus.

• Cleavage-Resistant TREM2 Restores Efferocytosis

  2026-08-20

  Dong et al. engineered a synthetic cleavage-resistant TREM2 receptor that preserves macrophage signaling and efferocytosis despite inflammatory ADAM17 activity. In mouse models of metabolic-dysfunction-associated steatohepatitis and atherosclerosis, phosphatidylserine-functionalized lipid nanoparticles delivered CRT mRNA in situ and reduced apoptotic-cell accumulation and inflammation.

• Dovitinib (TKI-258) Workflows for RTK Cancer Research

  2026-08-19

  Build more informative RTK assays with Dovitinib by combining phenotypic viability measurements, phospho-signaling readouts, and apoptosis markers. A chamber-specific cardiomyocyte study also offers a practical framework for controlling cellular identity when extending pathway experiments beyond conventional cancer models.

• PLK1 Control of p31comet in Checkpoint Disassembly

  2026-08-19

  The reference study identifies Polo-like kinase 1 as a direct regulator of p31comet, showing that PLK1 phosphorylation at S102 suppresses TRIP13-assisted disassembly of mitotic checkpoint complexes. This mechanism explains how active mitotic checkpoints avoid simultaneous MCC assembly and disassembly and provides a biochemical framework for interpreting PLK1 perturbation experiments.

• Cy5-UTP: Designing RNA Interaction Assays

  2026-08-18

  Cy5-UTP enables direct fluorescent RNA probe synthesis for FISH and transcript-mapping workflows. This guide connects Cyanine 5-uridine triphosphate labeling with the sequence-dependent RNA interactions revealed in a recent MALAT1 study, translating mechanistic insight into better assay design and interpretation.

• AMG 487 and the Context-Dependent CXCR3 Switch

  2026-08-18

  AMG 487 is more than a potent CXCR3 antagonist: it is a mechanistic probe for understanding how CXCL10-CXCR3 signaling, autophagy, and LAMP1 reshape macrophage behavior across inflammatory states. This article translates the latest evidence into an assay strategy for researchers developing robust inflammation and acute lung injury models.

• N2703: A Pathway-Informed Nicotine Research Tool

  2026-08-17

  Explore how 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) can support pathway-informed biomedical assays. This article connects nicotine biosynthesis, chemical perturbation, experimental controls, and responsible interpretation.

• ABT-263 and the Metabolic Logic of Cell Fate

  2026-08-17

  ABT-263 (Navitoclax) offers translational researchers a way to interrogate how Bcl-2-family buffering intersects with metabolic stress, senescence escape, and mitochondrial apoptotic priming. This thought-leadership perspective connects the hydride transfer complex described by Igelmann et al. with practical experimental strategies for cancer biology, apoptosis assays, and model selection.

• Canagliflozin Hemihydrate: SGLT2 Research Guide

  2026-08-16

  Canagliflozin hemihydrate is a high-purity small-molecule SGLT2 inhibitor for glucose metabolism research and diabetes mellitus research. Its established renal glucose reabsorption mechanism should not be confused with mTOR inhibition, which was not detected in a drug-sensitized yeast growth model.

• Tyrothricin: Membrane-Disruption Research Workflows

  2026-08-15

  Tyrothricin is a peptide antibiotic mixture suited to mechanism-focused bacterial and fungal assays, from rapid membrane-permeability tests to orthogonal growth and viability workflows. This guide connects practical assay design with a lens oxidative-stress study, showing how dynamic sampling and perturbation controls can improve interpretation without overstating cross-domain evidence.

7757 records 1/518 page Next 12345 下5页 Last page